Literature DB >> 23430405

Identification of regulatory relationships in Parkinson's disease.

Hao Wang1, Cheng Sun, Yusi Liang, Heying Zhang, Yonggang Tan.   

Abstract

Parkinson's disease is a complex chronic neurodegenerative disease common in elderly people and greatly affects the quality of their life. However, the pathogenesis of Parkinson's disease is still incompletely understood to date. The purpose of this present study is to explore the pathogenesis of Parkinson's disease using a computational bioinformatics analysis of gene expression. We downloaded gene expression profiles on Parkinson's disease from the Gene Expression Omnibus database and predicted the miRNAs and transcription factors of differentially expressed genes in Parkinson's disease. A total of 11 genes associated with Parkinson's disease initiation were identified, including junction plakoglobin (JUP). Besides, we identified a new transcription factor, N-Myc down-regulated gene 1 (NDRG1), which is regulated by miRNA-133 in Parkinson's disease. Furthermore, we proposed a hypothesis that there may be two kinds of regulatory relationships among miRNA-133, NDRG1, and JUP: direct regulatory relationship and indirect relationship. The results presented in this work confirmed the role of miRNA-133 in Parkinson's disease and substantiated our understanding of miRNA-related neurodegenerative states in general.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430405     DOI: 10.1007/s12031-012-9937-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  32 in total

1.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Molecular biology. miRNAs in neurodegeneration.

Authors:  Sébastien S Hébert; Bart De Strooper
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

Review 4.  Got target? Computational methods for microRNA target prediction and their extension.

Authors:  Hyeyoung Min; Sungroh Yoon
Journal:  Exp Mol Med       Date:  2010-04-30       Impact factor: 8.718

Review 5.  The Parkinson's complex: parkinsonism is just the tip of the iceberg.

Authors:  J William Langston
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

Review 6.  Neuropathology of autonomic nervous system in Parkinson's disease.

Authors:  K Wakabayashi; H Takahashi
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

7.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

Review 8.  Transcriptional control of midbrain dopaminergic neuron development.

Authors:  Siew-Lan Ang
Journal:  Development       Date:  2006-08-09       Impact factor: 6.868

9.  Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.

Authors:  Ingunn Holen; Jacob Whitworth; Faith Nutter; Alyson Evans; Hannah K Brown; Diane V Lefley; Ivana Barbaric; Mark Jones; Penelope D Ottewell
Journal:  Breast Cancer Res       Date:  2012-05-25       Impact factor: 6.466

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  2 in total

Review 1.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

2.  Molecule of the month: miRNA and Parkinson's disease protein PARK2.

Authors:  Paul Shapshak
Journal:  Bioinformation       Date:  2013-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.